V019-6487 Screening compound: 4-[4-(2,4-difluorophenoxy)-6-(4-fluorobenzenesulfonyl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine

V019-6487 Screening compound: 4-[4-(2,4-difluorophenoxy)-6-(4-fluorobenzenesulfonyl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine
V019-6487 Screening compound: 4-[4-(2,4-difluorophenoxy)-6-(4-fluorobenzenesulfonyl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound V019-6487
4-[4-(2,4-difluorophenoxy)-6-(4-fluorobenzenesulfonyl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-6487

Molecular Formula

C23H21F3N4O4S (C23 H21 F3 N4 O4 S)

Compound Name

4-[4-(2,4-difluorophenoxy)-6-(4-fluorobenzenesulfonyl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]morpholine

IUPAC name

4-[4-(24-difluorophenoxy)-6-(4-fluorobenzenesulfonyl)-5H6H7H8H-pyrido[43-d]pyrimidin-2-yl]morpholine

SMILES

O=S(c(cc1)ccc1F)(N(CCc1nc(N2CCOCC2)n2)Cc1c2Oc(ccc(F)c1)c1F)=O

InChI

InChI=1S/C23H21F3N4O4S/c24-15-1-4-17(5-2-15)35(31,32)30-8-7-20-18(14-30)22(34-21-6-3-16(25)13-19(21)26)28-23(27-20)29-9-11-33-12-10-29/h1-6,13H,7-12,14H2

InChI Key

NHMGZYJBWXHWED-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19933244

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

506.51

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.207

Distribution Coefficient, logD

4.207

Water Solubility, LogSw

-4.39

Polar Surface Area

69.563

Acid Dissociation Constant (pKa)

20.04

Base Dissociation Constant (pKb)

2.38

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.40

V019-6487 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anticancer Library (62698 compounds)

PI3K-Targeted Library (17255 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Kinases
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with V019-6487 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-6487?
Check Price and Availability of V019-6487, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V019-6487 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V019-6487
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V019-6487
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-6487 available by request